Sarah H. Saxton
Papers
1
Total Citations
52
H-Index
1
About
Sarah H. Saxton is a leading figure in biopharmaceutical engineering, with a primary focus on advancing drug screening technologies through robotic automation and tissue engineering. Her most impactful work, "Robotically handled whole-tissue culture system for the screening of oral drug formulations" (2020), has garnered 52 citations, establishing a new paradigm for high-throughput, physiologically relevant drug testing. Saxton’s major contribution lies in integrating robotic handling with whole-tissue cultures, enabling the precise, reproducible screening of oral drug formulations while preserving native tissue architecture and function. This innovation addresses a critical bottleneck in preclinical drug development, reducing reliance on animal models and accelerating the translation of oral therapeutics. Her research bridges mechanical engineering, cell biology, and pharmaceutical science, offering a scalable platform for personalized medicine. Saxton’s work is recognized for its translational impact, with her system being adopted by academic labs and industry partners for early-stage drug formulation testing. She continues to refine these automated platforms, aiming to expand their application to complex diseases and multi-tissue interactions.
Research Focus
Key Achievements
Top Papers
- 1